Indomethacin Impurity G

IMPURITIES

CAT No.# CS-P-08095
Category Impurities
CAS 402849-26-7
Stock Status
AVAILABLE ENQUIRE NOW View COA

(Available within 3-5 days)

Product maybe under re-certification or re-stock. Enquire now to know exact date of delivery and pricing.
Molecular Weight 392.24
Molecular Formula C19H15Cl2NO4
Purity: >98
Synonyms: [1-(3,4-Dichlorobenzoyl)-5-methoxy-2-methyl-1H-indol-3-yl]acetic Acid; 1-(3,4-Dichlorobenzoyl)-5-methoxy-2-methyl-1H-indol-3-acetic Acid; Indomethacin Impurity G; Indomethacin EP Impurity G
Application Notes: 3-Chloroindomethacin (Indomethacin EP Impurity G) is an impurity of Indomethacin (I641000) which inhibits cyclooxygenase (IC50=0.1uM) selectively over liposygenases (IC50=100uM for 5-,12- and 15-LO).
References: Salari, H., et al.: Prostagland. Leukotrienes Med., 13, 53 (1984), Lehmann, J.M., et al.: J. Biol. Chem., 272, 3406 (1997)
Shipping: Free Shipping for worldwide on order above 2000 USD
Indomethacin Impurity G Worldwide Suppliers of Indomethacin Impurity G Impurities Clearsynth CS-P-08095

Product rating: 9 Indomethacin Impurity G based on 20 ratings

  1. Impurities
  2. Indomethacin Impurity G


PEOPLE ALSO SEARCHED FOR: 1. propan-2-yl-5-hydroxy-2-methyl-2-4-(3-nitrophenyl)-6-oxo-1,4,5,5-tetraahydropyridine-3-carboxylate
2. ([13C6]Leu5)-Ghrelin (human) (H-7252.1000)
3. Lauroside D
4. Triazolam 13C D3
5. Icatibant impurity 1
6. BISPHENOL AF (RING-13C12)
7. 0.1% TFA in Water ULC-MS
8. Metamizole EP Impurity C HCl
9. Silodosin Metabolite D4
10. Silodosin Metabolite
11. 2-Phenoxymethanesulfonanilide
12. Nimesulide EP Impurity A
13. Acetone HPLC
14. Riluzole (1604337)
15. Pheniramine impurity B
16. Palbociclib N-Glucuronide
17. Carpropamid
18. Olmesartan N1-Trityl Impurity
19. 1-Octadecanethiol
20. H-Ser(Bzl)-OBzl . p-tosylate (E-3755.0005)


This page contains information about Indomethacin Impurity G Cas 402849-26-7 and its Impurities.

Indomethacin Impurity G Indomethacin Impurity G Worldwide Suppliers of Indomethacin Impurity G Impurities Clearsynth 402849-26-7

"Products currently covered by valid US Patents are offered for R&D use in accordance with 35 USC 271(e)+A13(1). Any patent infringement and resulting liability is solely at buyer risk."